SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 37 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $36,577,000 | -4.6% | 29,174,000 | 0.0% | 0.21% | -5.5% |
Q1 2022 | $38,359,000 | -10.2% | 29,174,000 | 0.0% | 0.22% | +5.8% |
Q4 2021 | $42,695,000 | -1.1% | 29,174,000 | 0.0% | 0.21% | +9.5% |
Q3 2021 | $43,167,000 | +12.2% | 29,174,000 | 0.0% | 0.19% | +12.4% |
Q2 2021 | $38,479,000 | +221.5% | 29,174,000 | +218.0% | 0.17% | +225.0% |
Q1 2021 | $11,970,000 | – | 9,174,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DLD Asset Management, LP | 10,370,000 | $17,732,700 | 1.93% |
CSS LLC/IL | 8,157,000 | $13,813,847 | 0.86% |
Worth Venture Partners, LLC | 917,000 | $1,562,052 | 0.85% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $8,887,187 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 2,495,000 | $4,354,555 | 0.10% |
Point72 Asset Management, L.P. | 9,007,000 | $15,327,332 | 0.05% |
PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,696,250 | 0.04% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,580,143 | 0.04% |
SSI INVESTMENT MANAGEMENT LLC | 141,000 | $237,703 | 0.02% |
LORD, ABBETT & CO. LLC | 3,005,000 | $5,066 | 0.02% |